Improving Rates of Diagnostic Colonoscopy in Native Americans
Launched by UNIVERSITY OF OKLAHOMA · Aug 4, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping Native American adults improve their chances of getting a follow-up colonoscopy after an abnormal home stool test, which can detect early signs of colorectal cancer (CRC). Colorectal cancer is a serious disease and a leading cause of cancer death in the U.S., and Native Americans face higher rates of this cancer and related deaths compared to other groups. The study aims to reduce these differences by making sure people complete important diagnostic tests on time.
People who might be eligible for this study are Native American adults between the ages of 45 and 75 who live in Oklahoma, speak English, and have access to email. Participants will be asked to take part in efforts to improve how quickly and easily they can get a colonoscopy after an abnormal stool screening result. This is important because timely follow-up can catch cancer early when treatment is most effective. The trial is not yet recruiting, but it hopes to support better health outcomes in Native American communities by improving cancer screening processes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 45-75
- • Live in Oklahoma
- • Fluent in English
- • Have access to email
- • Identify as Native American or have a Certificate of Degree of Indian Blood
- Exclusion Criteria:
- • -
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Patients applied
Trial Officials
Jordan Neil, PhD
Principal Investigator
University of Oklahoma
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported